Status:
UNKNOWN
IPTi in Mozambican Infants for Malaria Prevention
Lead Sponsor:
Hospital Clinic of Barcelona
Conditions:
Malaria
Eligibility:
All Genders
Up to 3 years
Phase:
PHASE1
PHASE2
Brief Summary
To evaluate if intermittent preventive treatment in infants (IPTi) consisting of SP \[Fansidar\] given through the EPI scheme alongside routine immunisations at 3, 4 and 9 months of age reduces de inc...
Detailed Description
The study is a randomised, double blind, placebo-controlled trial of the antimalarial drug sulphadoxine-pyrimethamine administered intermittently at 3, 4 and 9 months of age through the EPI scheme at ...
Eligibility Criteria
Inclusion
- Children from study area
- Signed informed consent
Exclusion
- History of drug allergies
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
1498 Patients enrolled
Trial Details
Trial ID
NCT00209794
Start Date
September 1 2002
End Date
December 1 2005
Last Update
November 16 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro de Investigaçao em Saude da Manhiça
Manhiça, Maputo Province, Mozambique